Thermo Fisher to Purchase Brammer Bio for $ 1.7 Billion

Thermo Fisher Scientific Inc. announced the purchase of Brammer Bio for $ 1.7 billion, which would strengthen the presence of the laboratory equipment company in the growing field of gene therapy.

Brammer Bio, a privately owned company owned by private equity firm Ampersand Capital Partners, provides pharmaceutical companies developing gene therapies and gene-modified cell therapies with outsourced research and drug manufacturing services.

Gene…